Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 2 Mar 2010 |
| Arzerra 2009 Net Sales Figures | 4 Feb 2010 |
| Genmab Outlicenses Zanolimumab to TenX Biopharma | 4 Feb 2010 |
| Major Shareholder Announcement | 3 Feb 2010 |
| Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemia | 22 Jan 2010 |